LITHI - PHARMA
The computed 12-month bankruptcy probability of LITHI - PHARMA is 0.2% (very low). The company has been active since 1993 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
| Active | 33 yrs |
| Board | 2 |
| Locations | 2 |
| Publications | 5 |
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 30-06-2025 | verkort | 29-12-2025 | 2026-00593285 |
| 30-06-2024 | verkort | 29-12-2024 | 2024-00628132 |
| 30-06-2023 | micro | 08-01-2024 | 2024-00545972 |
| 30-06-2022 | micro | 31-12-2022 | 2023-20552806 |
| 30-06-2021 | verkort | 30-11-2021 | 2021-78900250 |
| 30-06-2020 | verkort | 09-12-2020 | 2020-75200338 |
| 30-06-2019 | verkort | 03-01-2020 | 2020-00300419 |
| 30-06-2018 | verkort | 07-01-2019 | 2019-00600580 |
| 30-06-2017 | micro | 08-01-2018 | 2018-01000258 |
| 30-06-2016 | verkort | 03-01-2017 | 2017-00200006 |
-
Current13-11-2015 → present
2 events
- 05-11-2021 Mandate renewed· Director
- 13-11-2015 Mandate renewed· Director
-
Current13-11-2015 → present
4 events
- 05-11-2021 Mandate renewed· Director
- 05-11-2021 Appointed· Managing director
- 13-11-2015 Mandate renewed· Director
- 13-11-2015 Mandate renewed· Managing director
Former directors (1)
-
nv BioclinLegal entityDirector· perm. rep.: Thierry BaetsléState Gazette act 16018949 (04-02-2016)Former13-11-2015 → 01-01-2020
2 events
- 01-01-2020 Resigned· Managing director
- 13-11-2015 Appointed· Director
| NACE primary | 93130 |
| Legal form | Public limited company(014) |
| Incorporation | 06-01-1993 |
| Status | Active |
| Postal code | 8470 |
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 35005A1053/00N000 | Flanders | 910 m² | 1 · 140 m² | 6.5 m · 1 fl. |
| 35005B0271/00R000 | Flanders | 742 m² | 1 · 379 m² | 11.0 m · 3 fl. |
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
06-05-2026 Seat change · Officer appointment · Act object
- Filing: 2026-04-21 · LITHI - PHARMA
- Seat change: to: Zomerloosstraat 33 A, 8470 Gistel, from: Oostendse Baan 86, 8470 Gistel, effective_date: 2026-04-01 · LITHI - PHARMA
- Officer appointment: role: Bestuurder · Baetslé Thierry
- Publication: 2026-05-06
- Act object: Verplaatsing maatschappelijke zetel
Technical details
{
"facts": [
{
"type": "filing",
"quote": "NEERLEGGING TER GRIFFIE VAN DE ONDERNEMINGSRECHTBANK GENT afdeling OOSTENDE 21 APR. 2026",
"value": "2026-04-21",
"object": null,
"subject": "e1"
},
{
"type": "seat_change",
"quote": "Bij beslissing van de bestuurder dd 01/04/2026 wordt de maatschappelijke zetel vanaf 01/04/2026 verplaatst van Oostendse Baan 86, 8470 Gistel naar Zomerloosstraat 33 A, 8470 Gistel.",
"value": {
"to": "Zomerloosstraat 33 A, 8470 Gistel",
"from": "Oostendse Baan 86, 8470 Gistel",
"effective_date": "2026-04-01"
},
"object": null,
"subject": "e1"
},
{
"type": "officer_appointment",
"quote": "Baetsl\u00E9 Thierry Bestuurder",
"value": {
"role": "Bestuurder"
},
"object": "e1",
"subject": "e2"
},
{
"type": "publication",
"quote": "Belgisch Staatsblad - 06/05/2026",
"value": "2026-05-06",
"object": null,
"subject": null
},
{
"type": "act_object",
"quote": "Onderwerp akte: Verplaatsing maatschappelijke zetel",
"value": "Verplaatsing maatschappelijke zetel",
"object": null,
"subject": null
}
],
"act_meta": {
"model_id": 40,
"extractor": "open-capture-27b-v3",
"ocr_chars": 1069,
"truncated": false,
"needs_verify": true
},
"entities": [
{
"id": "e1",
"kbo": "0449.135.041",
"kind": "company",
"name": "LITHI - PHARMA",
"attrs": {
"new_seat": "Zomerloosstraat 33 A, 8470 Gistel",
"old_seat": "Oostendse Baan 86, 8470 Gistel",
"legal_form": "Naamloze vennootschap"
}
},
{
"id": "e2",
"kbo": null,
"kind": "person",
"name": "Baetsl\u00E9 Thierry",
"attrs": {
"role": "Bestuurder"
}
}
]
}02-12-2022 Publication in the Belgian Official Gazette, Minor change
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"detected_kind": "agm_rescheduling",
"effective_date": null,
"mandate_renewal": null,
"subject_company": {
"kbo": "0449.135.041",
"name_full": "LITHIPHARMA",
"legal_form": "NV"
},
"liquidation_closure": null,
"officer_designation": null,
"special_procuration": null,
"single_shareholder_declaration": null
}06-01-2022 1 director appointed, 2 reappointed
- Thierry Baetslé, Gedelegeerd bestuurder
- Thierry Baetslé, Bestuurder
- Lien Matton, Bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thierry Baetsl\u00E9",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-05",
"evidence_quote": "Met eenparigheid van stemmen beslist de algemene vergadering van 5 november 2021 vanaf die datum te herbenoemen als bestuurders en dit voor de duur van 6 jaar tot na de algemene vergadering van november 2027: -De heer Thierry Baetsl\u00E9"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lien Matton",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-05",
"evidence_quote": "Met eenparigheid van stemmen beslist de algemene vergadering van 5 november 2021 vanaf die datum te herbenoemen als bestuurders en dit voor de duur van 6 jaar tot na de algemene vergadering van november 2027: -Mevrouw Lien Matton"
},
{
"kind": "director_in",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Thierry Baetsl\u00E9",
"address": null,
"birth_date": null
},
"effective_date": "2021-11-05",
"evidence_quote": "Onmiddellijk na de algemene vergadering komt het bestuursorgaan bijeen en benoemt de heer Thierry Baetsl\u00E9 tot gedelegeerd bestuurder eveneens vanaf 5 november 2021 tot na de algemene vergadering van november 2027."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0449.135.041",
"name_full": "LITHIPHARMA",
"legal_form": "NV"
}
}11-01-2021 Thierry Baetslé resigns as managing director
- Thierry Baetslé, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_out",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Thierry Baetsl\u00E9",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "nv Bioclin",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2020-01-01",
"evidence_quote": "Met \u00E9\u00E9nparigheid van stemmen beslist de Algemene Vergadering van 13/11/2020 met ingang van 1 januari 2020 te ontslaan: nv Bioclin met vaste vertegenwoordiger de heer Thierry Baetsl\u00E9"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0449.135.041",
"name_full": "LITHIPHARMA",
"legal_form": "NV"
}
}04-02-2016 1 director appointed, 3 reappointed
- Thierry Baetslé, Bestuurder
- Thierry Baetslé, Bestuurder
- Lien Matton, Bestuurder
- Thierry Baetslé, Gedelegeerd bestuurder
Technical details
{
"events": [
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thierry Baetsl\u00E9",
"address": null,
"birth_date": null
},
"effective_date": "2015-11-13",
"evidence_quote": "Met \u00E9\u00E9nparigheid van stemmen beslist de Algemene Vergadering van 13 november 2015 vanaf die datum te herbenoemen als bestuurders tot de Algemene Vergadering er anders over beslist: - de heer Thierry Baetsl\u00E9"
},
{
"kind": "director_renew",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Lien Matton",
"address": null,
"birth_date": null
},
"effective_date": "2015-11-13",
"evidence_quote": "Met \u00E9\u00E9nparigheid van stemmen beslist de Algemene Vergadering van 13 november 2015 vanaf die datum te herbenoemen als bestuurders tot de Algemene Vergadering er anders over beslist: - mevrouw Lien Matton"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Thierry Baetsl\u00E9",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "nv Bioclin",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2015-11-13",
"evidence_quote": "Tevens wordt benoemd tot bestuurder: - nv Bioclin met vaste vertegenwoordiger de heer Thierry Baetsl\u00E9."
},
{
"kind": "director_renew",
"role": "gedelegeerd_bestuurder",
"person": {
"rrn": null,
"name": "Thierry Baetsl\u00E9",
"address": null,
"birth_date": null
},
"effective_date": "2015-11-13",
"evidence_quote": "Onmiddellijk hierna komt de Raad van Bestuur bijeen en herbenoemt de heer Thierry Baetsl\u00E9 tot gedelegeerd bestuurder dit voor de duur van 6 jaar tot na de Algemene Vergadering van november 2021."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0449.135.041",
"name_full": "LITHIPHARMA",
"legal_form": "NV"
}
}Generate a structured, factual brief from every signal in this dossier: risk, financial health, ownership, mandates and sector comparison.
| Legal nameNL | LITHI - PHARMA |